Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01)

IntroductionAim of the present study was to evaluate the real-world impact of once-weekly (OW) subcutaneous semaglutide on different end-points indicative of metabolic control, cardiovascular risk factors, and beta-cell function in type 2 diabetes (T2D).MethodsThis was a retrospective, observational...

Full description

Bibliographic Details

Published in:	Frontiers in Endocrinology
Main Authors:	Cesare C. Berra, Maria Chiara Rossi, Marco Mirani, Daniela Ceccarelli Ceccarelli, Cristina Romano, Lorenza Sassi, Elena Peretti, Giuseppe Favacchio, Ida Pastore, Laura Folini, Giusi Graziano, Maria Elena Lunati, Sebastiano Bruno Solerte, Paolo Fiorina
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Subjects:	type 2 diabetes semaglutide effectiveness HbA1c cardiovascular risk factors beta-cell function
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1099451/full